Breast cancer is a heterogeneous disease in which estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 play crucial roles in molecular subtyping, diagnosis, treatment, and prognosis, showing positivity in nearly 90% of cases. This evidence concerns the gene MKI67 and breast carcinoma.